Arbekacin as an Alternative Drug to Teicoplanin for the Treatment of MRSA Infection

被引：1
|
作者：
Hwang, Ji-Hee [1 ]
Lee, Ju-Hyung [2 ]
Kim, Ju-Sin [1 ]
Hwang, Jeong-Hwan [3 ,4 ,5 ]
Lee, Chang-Seop [3 ,4 ,5 ]
机构：
[1] Chonbuk Natl Univ Hosp, Dept Pharm, Jeonju, South Korea
[2] Chonbuk Natl Univ, Dept Prevent Med, 567 Baekje Daero, Jeonju 54907, South Korea
[3] Chonbuk Natl Univ, Dept Internal Med, 567 Baekje Daero, Jeonju 54907, South Korea
[4] Chonbuk Natl Univ, Res Inst Clin Med, 567 Baekje Daero, Jeonju 54907, South Korea
[5] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju, South Korea
来源：
YONSEI MEDICAL JOURNAL | 2016年 / 57卷 / 04期
关键词：
RESISTANT STAPHYLOCOCCUS-AUREUS; VANCOMYCIN;
D O I：
10.3349/ymj.2016.57.4.1047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1047 / 1048
页数：2
相关论文
共 50 条
  • [1] Teicoplanin as an Effective Alternative to Vancomycin for Treatment of MRSA Infection in Chinese Population: A Meta-analysis of Randomized Controlled Trials
    Peng, Yang
    Ye, Xiaohua
    Li, Ying
    Bu, Tao
    Chen, Xiaofeng
    Bi, Jiaqi
    Zhou, Junli
    Yao, Zhenjiang
    PLOS ONE, 2013, 8 (11):
  • [2] The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection
    Yamamoto, Yoshihiro
    Izumikawa, Koichi
    Hashiguchi, Koji
    Fukuda, Yuichi
    Kobayashi, Tsutomu
    Kondo, Akira
    Inoue, Yuichi
    Morinaga, Yoshitomo
    Nakamura, Shigeki
    Imamura, Yoshifumi
    Miyazaki, Taiga
    Kakeya, Hiroshi
    Yanagihara, Katsunori
    Kohno, Shigeru
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (02) : 241 - 246
  • [3] The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study
    Hwang, Ji-Hee
    Lee, Ju-Hyung
    Moon, Mi-Kyoung
    Kim, Ju-Sin
    Won, Kyoung-Suk
    Lee, Chang-Seop
    INFECTION AND CHEMOTHERAPY, 2013, 45 (01) : 62 - 68
  • [4] Pharmacodynamics of teicoplanin against MRSA
    Ramos-Martin, V.
    Johnson, A.
    McEntee, L.
    Farrington, N.
    Padmore, K.
    Cojutti, P.
    Pea, F.
    Neely, M. N.
    Hope, W. W.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (12) : 3382 - 3389
  • [5] Treatment of MRSA Infection: Where are We?
    Nazli, Adila
    Tao, Wenlan
    You, Hengyao
    He, Xiaoli
    He, Yun
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (28) : 4425 - 4460
  • [6] Efficacy and safety of linezolid versus teicoplanin for the treatment of MRSA infections: a meta-analysis
    Chen, Hao
    Li, Lan
    Liu, Yanyan
    Wu, Maomao
    Xu, Shuangli
    Wang, Mingli
    Li, Jiabin
    Huang, Xiaohui
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2017, 11 (12): : 926 - 934
  • [7] Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA
    Horn, Karolyn S.
    Danziger, Larry H.
    Rodvold, Keith A.
    Glowacki, Robert C.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (04) : 463 - 472
  • [8] Treatment intensity and characteristics of MRSA infection in CF
    Muhlebach, Marianne S.
    Miller, Meredith
    LaVange, Lisa M.
    Mayhew, Greg
    Goodrich, Jennifer S.
    Miller, Melissa B.
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (03) : 201 - 206
  • [9] What's new in the treatment of serious MRSA infection?
    Holmes, Natasha E.
    Howden, Benjamin P.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2014, 27 (06) : 471 - 478
  • [10] DUAL LOCAL DRUG DELIVERY OF VANCOMYCIN AND FARNESOL FOR MITIGATION OF MRSA INFECTION IN VIVO -A PILOT STUDY
    Woelfle, U. C.
    Briggs, T.
    Bhattacharyya, S.
    Qu, H.
    Sheth, N.
    Knabe, C.
    Ducheyne, P.
    EUROPEAN CELLS & MATERIALS, 2020, 40 : 38 - 57
12345